Boston, Massachusetts-based PTC Inc. (PTC) provides software solutions and services globally that aid manufacturing companies in designing, operating, and managing products. With a market cap. of $18.

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has withdrawn the New Drug Application (NDA) resubmission for ...

PTC Therapeutics withdrew a New Drug Application for Translarna, a muscular dystrophy treatment, after the Food and Drug Administration indicated it would likely not grant approval.

Wall Street expects a year-over-year increase in earnings on higher revenues when PTC Therapeutics (PTCT) reports results for ...

Enables faster, more collaborative product execution with a cloud-based PLM solution built to support future growth BOSTON, ...

Investing.com -- PTC Inc (NASDAQ:PTC) stock fell 3.8% on Thursday after Google announced a major upgrade to its Gemini 3 Deep Think AI system, potentially challenging PTC’s position in the engineering ...

Product design software company PTC (NASDAQ:PTC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with ...

PTC repurchased $200 million in common stock during Q1 and plans to increase buybacks to $250 million in Q2, targeting a ...

J.P. Morgan upgraded Autodesk (ADSK) to Overweight and downgraded PTC (PTC) to Underweight citing diverging fundamentals ...

Honorees recognized at PTC’s largest annual conference in its 48 year history Each recipient is contributing in ...

PTC Inc. (NASDAQ:PTC) defied analyst predictions to release its quarterly results, which were ahead of market expectations. The company beat forecasts, with revenue of US$686m, some 8.1% above ...